[1]32例原发性中枢神经系统恶性淋巴瘤临床分析及文献复习 [2]A prospective study on the circulation and central nervous system after primary central nervous system B cell lymphoma treatment with rituximab. [3]奥布替尼ICP-022治疗复发或难治性原发或继发中枢神经系统淋巴瘤试验 [4]含美罗华方案治疗B细胞性惰性淋巴瘤34例报告 [5]利妥昔单抗联合挽救化疗治疗复发或难治弥漫大B细胞性非霍奇金淋巴瘤的长期随访结果 [6]利妥昔单抗快速脱敏治疗病例报告/病例系列的系统评价 [7]BTK inhibition in primary central nervous system lymphoma: mechanisms, clinical efficacy, and future perspectives [8]The Prognostic Significance of Pontine-White Matter Score in Primary Central Nervous System Lymphoma Patients [9]利妥昔单抗增敏navelbine诱导淋巴瘤细胞凋亡的实验研究 [10]弥漫大B细胞性淋巴瘤临床病理特点与利妥昔单抗疗效的关系